Short-term effects of an erbium/neodymium laser combination in superficial dyspareunia: a pilot study

Gambacciani, Marco; Fidecicchi, Tiziana

doi:10.1080/13697137.2021.2014809

Cited by 10 publications

(29 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The effectiveness of VEL+Nd:YAG therapy may be independent of years since menopause as it can be conducted in post-menopausal women with superficial dyspareunia [6]. VEL therapy involves energy carried by laser irradiation that reacts with the moisture in the mucous membrane to generate heat, achieving a resurfacing effect.…”

Section: Discussionmentioning

confidence: 99%

“…Renovalase TM (Fotona SP Dynamis, SMOOTH mode; Fotona, Ljubljana, Slovenia) protocol was used at a wavelength of 2,940 nm. The laser spot diameter was 7 mm, frequency was 1.6 Hz, and pulse fluence (laser energy emitted per unit area) was 1.75 J/cm 2 , as previously reported, to prevent tissue ablation with a deep thermal effect [6,7]. A specially designed glass vaginal speculum was used to insert the probe (R11) into the vaginal speculum and avoid contact with the vaginal mucosa.…”

Section: Figure 1: Cystoscopic Changes Before and After Laser Treatmentmentioning

confidence: 99%

“…After VEL therapy, Nd:YAG therapy was conducted using an Nd:YAG laser (Fotona SP Dynamis, PIANO mode), an R33 non-contact handpiece with a spot size of 9 mm, PIANO pulse mode (5 s), and fluence of 90 J/cm 2 . Six passes were conducted in the brushing mode to treat the posterior commissure [6]. The VEL and Nd:YAG therapies were conducted during the same sessions with no gap between exposures to the two energies.…”

Section: Figure 1: Cystoscopic Changes Before and After Laser Treatmentmentioning

confidence: 99%

“…It involves the simultaneous implementation of VEL:YAG laser irradiation accompanied by long pulse and very weak vulvar Nd:YAG laser irradiation. In superficial dyspareunia, VEL+Nd:YAG therapy is significantly more effective for improving vulvar pain than VEL alone [6]. Improvements in urinary symptoms were reported in women with IC/BPS who underwent monthly VEL for one year [7].…”

Section: Introductionmentioning

confidence: 97%

“…Combined vaginal erbium (VEL)/neodymium (Nd:YAG) laser (VEL+Nd:YAG) therapy is a proposed alternative to LET for vulvar pain [6]. It involves the simultaneous implementation of VEL:YAG laser irradiation accompanied by long pulse and very weak vulvar Nd:YAG laser irradiation.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Is Erbium/Neodymium Laser Combination Therapy an Effective Treatment Option for Interstitial Cystitis/Bladder Pain Syndrome With Vulvodynia?

Okui¹,

Okui²,

Gambacciani³

2022

Cureus

View full text Add to dashboard Cite

Interstitial cystitis/bladder pain syndrome (IC/BPS) is often associated with vulvodynia and poor vaginal health. IC/BPS causes pelvic and bladder pain and urinary symptoms, which considerably reduce the quality of life. To date, this condition has no definitive cure. Local estrogen therapy (LET) has been proposed as a treatment for vulvodynia and poor vaginal health to improve the symptoms of IC/BPS. However, chronic LET could be contraindicated or not desired in some patients. The present study reports the case of a 55-year-old postmenopausal woman with IC/BPS who was successfully treated with combined vaginal erbium (VEL)/neodymium (Nd:YAG) laser (VEL+Nd:YAG) therapy. The patient presented with a five-year history of pelvic pain and urinary frequency. Direct approaches for the bladder (such as hydrodistension, anticholinergic drugs, and transurethral Hunner lesion ablation/cauterization) were conducted with inconsistent results. Immediately prior to the patient's presentation, LET was administered for 12 weeks; however, this therapy resulted in mild improvement and poor patient satisfaction. After presentation, VEL+Nd:YAG therapy was conducted once a month for three months. The patient reported considerable decrease in pain during urination. The improved symptoms were maintained for six months after the last therapy session. These results suggest that VEL+Nd:YAG therapy is an effective method for improving symptoms in patients with IC/BPS.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Figure 1: Cystoscopic Changes Before and After Laser Treatmentmentioning

confidence: 99%

Section: Figure 1: Cystoscopic Changes Before and After Laser Treatmentmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 97%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Is Erbium/Neodymium Laser Combination Therapy an Effective Treatment Option for Interstitial Cystitis/Bladder Pain Syndrome With Vulvodynia?

Okui¹,

Okui²,

Gambacciani³

2022

Cureus

View full text Add to dashboard Cite

show abstract

Examining vaginal and vulvar health and sexual dysfunction in patients with interstitial cystitis (UNICORN-1 study)

Okui

Okui²,

Gambacciani

2022

Int Urogynecol J

View full text Add to dashboard Cite

BPS/IC and Vulvodynia: A Comprehensive Review of Laser Treatments and Common Pathophysiological Pathways

Okui

2024

Curr Bladder Dysfunct Rep

View full text Add to dashboard Cite

Short-term effects of an erbium/neodymium laser combination in superficial dyspareunia: a pilot study

Cited by 10 publications

References 17 publications

Is Erbium/Neodymium Laser Combination Therapy an Effective Treatment Option for Interstitial Cystitis/Bladder Pain Syndrome With Vulvodynia?

Is Erbium/Neodymium Laser Combination Therapy an Effective Treatment Option for Interstitial Cystitis/Bladder Pain Syndrome With Vulvodynia?

Examining vaginal and vulvar health and sexual dysfunction in patients with interstitial cystitis (UNICORN-1 study)

BPS/IC and Vulvodynia: A Comprehensive Review of Laser Treatments and Common Pathophysiological Pathways

Contact Info

Product

Resources

About